ulcerative colitis

Exclusive: Connect Biopharma reports a PhII fail for Zeposia challenger, and execs appear ready to punt
Endpoints
Tue, 05/3/22 - 10:46 pm
Connect Biopharma
Pfizer
Bristol Myers Squibb
FDA
clinical trials
ulcerative colitis
CBP-307
FDA guidance machine churns out 8 new documents in less than a week
Endpoints
Mon, 05/2/22 - 06:17 pm
FDA
regulatory
ulcerative colitis
Crohn's Disease
cancer
clinical trials
Xbiome acquires live biotherapeutic product program targeting ulcerative colitis
Biopharma Reporter
Thu, 04/28/22 - 10:39 pm
Xbiome
microbiome
hepatitis B
artificial intelligence
ulcerative colitis
Not IDEAL: Protagonist sinks as high dose of oral Entyvio rival fails in ulcerative colitis
Fierce Biotech
Tue, 04/26/22 - 10:16 am
Protagonist Therapeutics
clinical trials
ulcerative colitis
Entyvio
Phase 2 deja vu for gossamer bio after ulcerative colitis med flops
Fierce Biotech
Mon, 04/25/22 - 10:37 pm
Gossamer Bio
ulcerative colitis
clinical trials
GB004
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Wed, 04/6/22 - 11:52 am
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Protagonist seeks an Ideal readout
EP Vantage
Wed, 04/6/22 - 11:37 am
Protagonist Therapeutics
PN-943
clinical trials
ulcerative colitis
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Fierce Biotech
Tue, 03/29/22 - 10:50 am
Pfizer
ulcerative colitis
etrasimod
Arena Pharmaceuticals
clinical trials
Pfizer Lining Up New UC Drug, Former Employees Launch Counter Suit
BioSpace
Wed, 03/23/22 - 10:56 pm
Pfizer
ulcerative colitis
Xeljanz
Could This Be Eli Lilly's Next Blockbuster Drug?
Motley Fool
Sun, 03/20/22 - 11:01 pm
Eli Lilly
mirikizumab
ulcerative colitis
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months
Fierce Pharma
Thu, 03/17/22 - 11:33 pm
AbbVie
Rinvoq
ulcerative colitis
FDA
Lilly unveils mirikizumab data in ulcerative colitis as it preps filings
Pharmaforum
Mon, 02/21/22 - 10:36 am
Eli Lilly
mirikizumab
ulcerative colitis
clinical trials
Bristol Myers Squibb Just Got Some Great Regulatory News
Motley Fool
Tue, 11/2/21 - 10:45 am
Bristol Myers Squibb
Zeposia
Europe
ulcerative colitis
Bristol Myers Squibb's deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster
Fierce Biotech
Thu, 10/7/21 - 11:24 am
Bristol Myers Squibb
deucravacitinib
Amgen
Otzela
psoriasis
ulcerative colitis
Theravance takes a gut punch as J&J-partnered JAK drug flops key test in ulcerative colitis
Endpoints
Mon, 08/23/21 - 11:26 pm
Theravance
izencitinib
ulcerative colitis
Crohn’s disease
clinical trials
Seres Therapeutics’ microbiome therapy flops against placebo as shares go into freefall
Fierce Biotech
Thu, 07/22/21 - 11:07 am
Seres Therapeutics
microbiome
ulcerative colitis
SER-287
clinical trials
Galapagos avoids 'complete whiff' as key anti-inflammatory drug fails to beat placebo in midphase trials
Fierce Biotech
Thu, 07/15/21 - 12:25 pm
Galapagos
clinical trials
rheumatoid arthritis
ulcerative colitis
psoriasis
filgotinib
Galapagos Touts Positive Post-Hoc Data, but Likely Won’t Gun for US Approval
BioSpace
Mon, 07/12/21 - 11:35 pm
Galapagos
ulcerative colitis
filgotinib
AbbVie says Rinvoq shines again as maintenance therapy for ulcerative colitis — but safety concerns still loom over JAK class
Endpoints
Wed, 06/30/21 - 10:49 am
AbbVie
ulcerative colitis
clinical trials
Rinvoq
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy

Pages